Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue
AMCP Supports S. 974, the CREATES ACT
On behalf of the Academy of Managed Care Pharmacy (AMCP), I wanted to take this opportunity to express our strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974), bipartisan legislation to increase competition and patient access to safe and affordable generic and biosimilar medicines. AMCP is pleased that you will be holding a hearing on this important legislation soon. We are encouraged that the legislation has bipartisan support and optimistic that with that support the Committee will mark-up the bill and advance it to the Senate floor for consideration.
Related
AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
